Left Main Coronary Artery Revascularization in Patients with Impaired Renal Function: Percutaneous Coronary
Amin Daoulah1, Rasha Taha Baqais2, Alwaleed Aljohar3
1Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Saudi Arabia.
Insights
Percutaneous coronary intervention (PCI) shows an in-hospital advantage over coronary artery bypass grafting (CABG) for left main coronary artery disease in patients with kidney issues. Long-term outcomes were similar for both PCI and CABG, regardless of renal function.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Nephrology
Background:
- Optimal revascularization strategy for left main coronary artery (LMCA) disease in patients with impaired renal function remains unclear.
- Limited evidence exists comparing percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in this specific patient population.
Purpose of the Study:
- To compare the clinical outcomes of PCI versus CABG for LMCA disease treatment.
- To evaluate outcomes in patients stratified by renal function status (impaired vs. normal).
Main Methods:
- Retrospective cohort study of 2,138 patients from 14 centers (2015-2019).
- Compared PCI vs. CABG in patients with impaired renal function (PCI: n=316, CABG: n=121).
- Compared PCI vs. CABG in patients with normal renal function (PCI: n=906, CABG: n=795).
- Primary outcomes: in-hospital and follow-up major adverse cardiovascular and cerebrovascular events (MACCE).
Main Results:
- In-hospital MACCE risk was significantly higher with CABG compared to PCI in both impaired (OR: 8.13) and normal renal function groups (OR: 2.59).
- No significant difference in follow-up MACCE between PCI and CABG was observed in patients with impaired renal function (HR: 1.14).
- Follow-up MACCE rates were also comparable between PCI and CABG in patients with normal renal function (HR: 1.12).
Conclusions:
- PCI may offer an advantage over CABG regarding in-hospital MACCE for LMCA disease in patients with impaired renal function.
- Long-term MACCE outcomes are comparable between PCI and CABG, irrespective of renal function status.
Introduction:
The evidence about the optimal revascularization strategy in patients with left main coronary artery (LMCA) disease and impaired renal function is limited. Thus, we aimed to compare the outcomes of LMCA disease revascularization (percutaneous coronary intervention [PCI] vs. coronary artery bypass grafting [CABG]) in patients with and without impaired renal function.
Methods:
This retrospective cohort study included 2,138 patients recruited from 14 centers between 2015 and 2,019. We compared patients with impaired renal function who had PCI (n= 316) to those who had CABG (n = 121) and compared patients with normal renal function who had PCI (n = 906) to those who had CABG (n = 795). The study outcomes were in-hospital and follow-up major adverse cardiovascular and cerebrovascular events (MACCE).
Results:
Multivariable logistic regression analysis showed that the risk of in-hospital MACCE was significantly higher in CABG compared to PCI in patients with impaired renal function (odds ratio [OR]: 8.13 [95% CI: 4.19-15.76], p < 0.001) and normal renal function (OR: 2.59 [95% CI: 1.79-3.73]; p < 0.001). There were no differences in follow-up MACCE between CABG and PCI in patients with impaired renal function (HR: 1.14 [95% CI: 0.71-1.81], p = 0.585) and normal renal function (HR: 1.12 [0.90-1.39], p = 0.312).
Conclusions:
PCI could have an advantage over CABG in revascularization of LMCA disease in patients with impaired renal function regarding in-hospital MACCE. The follow-up MACCE was comparable between PCI and CABG in patients with impaired and normal renal function.
Related Concept Videos
Kidney Transplant I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Coronary Artery Disease V: Interprofessional Care
Continuous Renal Replacement Therapy
Kidney Transplant II: Surgical Procedure
Cardiac Catheterization III: Left Heart Catheterization


